IL291548A - Trazodone compositions for children and methods of treating them - Google Patents
Trazodone compositions for children and methods of treating themInfo
- Publication number
- IL291548A IL291548A IL291548A IL29154822A IL291548A IL 291548 A IL291548 A IL 291548A IL 291548 A IL291548 A IL 291548A IL 29154822 A IL29154822 A IL 29154822A IL 291548 A IL291548 A IL 291548A
- Authority
- IL
- Israel
- Prior art keywords
- trazodone
- pediatric
- compositions
- treatment
- trazodone compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 title 1
- 229960003991 trazodone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962906166P | 2019-09-26 | 2019-09-26 | |
| PCT/EP2020/077017 WO2021058810A1 (en) | 2019-09-26 | 2020-09-25 | Pediatric trazodone compositions and method of treatment thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL291548A true IL291548A (en) | 2022-05-01 |
Family
ID=72665264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL291548A IL291548A (en) | 2019-09-26 | 2022-03-21 | Trazodone compositions for children and methods of treating them |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12514856B2 (enExample) |
| EP (1) | EP4034117A1 (enExample) |
| JP (1) | JP7629453B2 (enExample) |
| KR (1) | KR102936358B1 (enExample) |
| CN (1) | CN114615983A (enExample) |
| AU (1) | AU2020354534B2 (enExample) |
| BR (1) | BR112022005343A2 (enExample) |
| CA (1) | CA3153639A1 (enExample) |
| GE (2) | GEP20257739B (enExample) |
| IL (1) | IL291548A (enExample) |
| MX (1) | MX2022003442A (enExample) |
| UA (1) | UA129270C2 (enExample) |
| WO (1) | WO2021058810A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240173315A1 (en) * | 2022-11-14 | 2024-05-30 | OWP Pharmaceuticals, Inc. | Trazodone oral solution |
| US20240390277A1 (en) * | 2023-04-15 | 2024-11-28 | Rubicon Research Private Limited | Liquid formulations of trazodone |
| CN119280155B (zh) * | 2024-12-11 | 2025-02-25 | 新基元(北京)医药科技有限公司 | 一种改善稳定性的盐酸曲唑酮液体药物组合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1931346T1 (sl) | 2005-09-09 | 2012-10-30 | Angelini Labopharm Llc | Trazodonski sestavek za dajanje enkrat dnevno |
| ITMI20071573A1 (it) * | 2007-07-31 | 2009-02-01 | Acraf | Composizione farmaceutica liquida stabile a base di trazodone |
| ITMI20071603A1 (it) | 2007-08-03 | 2009-02-04 | Acraf | Trazodone e trazodone cloridrato in forma purificata |
-
2020
- 2020-09-25 MX MX2022003442A patent/MX2022003442A/es unknown
- 2020-09-25 UA UAA202201314A patent/UA129270C2/uk unknown
- 2020-09-25 AU AU2020354534A patent/AU2020354534B2/en active Active
- 2020-09-25 CA CA3153639A patent/CA3153639A1/en active Pending
- 2020-09-25 GE GEAP202015936A patent/GEP20257739B/en unknown
- 2020-09-25 KR KR1020227011618A patent/KR102936358B1/ko active Active
- 2020-09-25 EP EP20781357.7A patent/EP4034117A1/en active Pending
- 2020-09-25 JP JP2022518971A patent/JP7629453B2/ja active Active
- 2020-09-25 WO PCT/EP2020/077017 patent/WO2021058810A1/en not_active Ceased
- 2020-09-25 BR BR112022005343A patent/BR112022005343A2/pt unknown
- 2020-09-25 GE GEAP202415936A patent/GEAP202415936A/en unknown
- 2020-09-25 CN CN202080066712.7A patent/CN114615983A/zh active Pending
- 2020-09-25 US US17/763,037 patent/US12514856B2/en active Active
-
2022
- 2022-03-21 IL IL291548A patent/IL291548A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022549473A (ja) | 2022-11-25 |
| JP7629453B2 (ja) | 2025-02-13 |
| CA3153639A1 (en) | 2021-04-01 |
| GEAP202415936A (en) | 2024-10-28 |
| WO2021058810A1 (en) | 2021-04-01 |
| MX2022003442A (es) | 2022-07-11 |
| BR112022005343A2 (pt) | 2022-06-14 |
| GEP20257739B (en) | 2025-02-25 |
| US12514856B2 (en) | 2026-01-06 |
| KR102936358B1 (ko) | 2026-03-10 |
| EP4034117A1 (en) | 2022-08-03 |
| KR20220080096A (ko) | 2022-06-14 |
| US20220331312A1 (en) | 2022-10-20 |
| UA129270C2 (uk) | 2025-03-05 |
| AU2020354534B2 (en) | 2025-10-02 |
| CN114615983A (zh) | 2022-06-10 |
| AU2020354534A1 (en) | 2022-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276494A (en) | Niraprib formulations for children and methods for treating children | |
| SG11202103033WA (en) | Compositions and methods for the treatment of presbyopia | |
| IL278978A (en) | Preparations and methods for treating eczema | |
| IL287802A (en) | Preparations and methods for the treatment of eye diseases | |
| PT4076461T (pt) | Lumateperona para utilização no tratamento da esquizofrenia | |
| IL272937A (en) | Preparations and methods for the treatment of diseases involving fibrosis | |
| IL290983A (en) | Treatment methods | |
| EP4003246A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA | |
| EP4058029C0 (en) | MULTIMODAL COMPOSITIONS AND TREATMENT METHODS | |
| IL288415A (en) | Combinations and methods for the treatment of hemochromatosis | |
| EP3836953A4 (en) | Compositions and methods for treatment of acute lung injury | |
| GB201905810D0 (en) | Method of treatment | |
| IL289236A (en) | Preparations and methods for treating fungal infections | |
| SG11202003300WA (en) | Compositions and methods for treatment of fibrosis | |
| IL287441A (en) | Preparations and methods of use for the treatment of dry eye | |
| IL287538A (en) | Preparations and methods for the treatment of cancer | |
| EP4003341A4 (en) | COMPOSITIONS AND METHODS OF TREATING PRESBYOPIA | |
| EP4013773A4 (en) | Compositions and methods for treatment | |
| GB201810923D0 (en) | Compositions and method of treatment | |
| GB201913122D0 (en) | Compositions and methods for treatment of cholangiocarcinoma | |
| GB201918853D0 (en) | Methods of treatment | |
| IL304191A (en) | elagolix administration methods | |
| EP3512550A4 (en) | COMPOSITIONS AND METHODS FOR TREATING ENTEROVIRUS INFECTIONS | |
| HK40071095A (en) | Pediatric trazodone compositions and method of treatment thereof | |
| GB201913124D0 (en) | Compositions and methods for treatment of cholangiocarcinoma |